Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Moderna in the Drug Discovery & Development Pharma 50

Moderna

Rank: 23

2021 Rank: na

Cambridge, Massachusetts, United States
https://www.modernatx.com

2021 Revenues ($USD) : $18,471,000,000
2021 R&D spend : $1,991,000,000
2021 Number of Employees : 2,700
Fiscal Year End : 12/31/2021
Leader : CEO Stéphane Bancel

A newcomer to pharma’s upper echelon, Moderna presently has a single commercialized product — its COVID-19 vaccine. That said, with $17.7 billion in sales, its Spikevax helped fuel pipeline progress. In March 2022, the company predicted its Spikevax vaccine would generate $21 billion in annual sales. Moderna is also working to develop vaccines to target a variety of next-gen COVID-19 vaccines. The company now has more than 40 product candidates in development. —BB

Moderna

[Moderna colleagues performing analysis using a PCR thermocycler. Image courtesy of Moderna.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE